Johnson & Johnson Revenue 2012-2026 | JNJ

Johnson & Johnson revenue for the twelve months ending March 31, 2026 was $96.362B, a 7.87% increase year-over-year.

  • Johnson & Johnson annual revenue for 2025 was $94.193B, a 6.05% increase from 2024.
  • Johnson & Johnson annual revenue for 2024 was $88.821B, a 4.3% increase from 2023.
  • Johnson & Johnson annual revenue for 2023 was $85.159B, a 6.46% increase from 2022.

Johnson & Johnson Revenue 2012-2026 | JNJ

  • Johnson & Johnson annual revenue for 2025 was $94.193B, a 6.05% increase from 2024.
  • Johnson & Johnson annual revenue for 2024 was $88.821B, a 4.3% increase from 2023.
  • Johnson & Johnson annual revenue for 2023 was $85.159B, a 6.46% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B